Immune responses to west nile virus infection in the central nervous system

Viruses

Volumn 4, Issue 12, 2012, Pages 3812-3830

  Cho, Hyelim ^a   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive immunity; Brain; Flavivirus; Immunopathogenesis; Innate immunity; Neuron; Pathogenesis

Indexed keywords

CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DISEASE COURSE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; NONHUMAN; REVIEW; VIRAL CLEARANCE; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS IMMUNITY; VIRUS PATHOGENESIS; WEST NILE FLAVIVIRUS;

ANIMALS; CENTRAL NERVOUS SYSTEM; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRAL TROPISM; VIRUS INTERNALIZATION; WEST NILE FEVER; WEST NILE VIRUS;

ANIMALIA; FLAVIVIRUS; VERTEBRATA; WEST NILE VIRUS;

EID: 84871863044     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v4123812     Document Type: Review

References (125)

1. Hayes, E.B.; Komar, N.; Nasci, R.S.; Montgomery, S.P.; O'Leary, D.R.; Campbell, G.L. Epidemiology and transmission dynamics of West Nile virus disease. Emerging Infect. Dis. 2005, 11, 1167-1173.
2. Smithburn, K.C.; Hughes, T.P.; Burke, A.W.; Paul, J.H. A Neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop Med. Hyg. 1940, 1, 471-492.
3. Kleiboeker, S.B. West Nile Virus. In Encyclopedia of Environmental Health; Nriagu, J.O., Ed.; Elsevier: Burlington, Canada, 2011; pp. 761-768.
4. Hubálek, Z.; Halouzka, J. West nile fever-A reemerging mosquito-borne viral disease in Europe. Emerging Infect. Dis. 1999, 5, 643-650.
5. Omalu, B.I.; Shakir, A.A.; Wang, G.; Lipkin, W.I.; Wiley, C.A. Fatal fulminant pan-meningo-polioencephalitis due to West Nile virus. Brain Pathol. 2003, 13, 465-472.
6. Armah, H.B.; Wang, G.; Omalu, B.I.; Tesh, R.B.; Gyure, K.A.; Chute, D.J.; Smith, R.D.; Dulai, P.; Vinters, H.V.; Kleinschmidt-DeMasters, B.K.; Wiley, C.A. Systemic distribution of West Nile virus infection: Postmortem immunohistochemical study of six cases. Brain Pathol. 2007, 17, 354-362.
7. Busch, M.P.; Wright, D.J.; Custer, B.; Tobler, L.H.; Stramer, S.L.; Kleinman, S.H.; Prince, H.E.; Bianco, C.; Foster, G.; Petersen, L.R.; et al. West nile virus infections projected from blood donor screening data, United States, 2003. Emerg. Infect. Dis. 2006, 12, 395-402.
8. Leis, A.A.; Fratkin, J.; Stokic, D.S.; Harrington, T.; Webb, R.M.; Slavinski, S.A. West Nile poliomyelitis. Lancet Infect. Dis. 2003, 3, 9-10.
9. Sejvar, J.J.; Haddad, M.B.; Tierney, B.C.; Campbell, G.L.; Marfin, A.A.; Van Gerpen, J.A.; Fleischauer, A.; Leis, A.A.; Stokic, D.S.; Petersen, L.R. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003, 290, 511-515.
10. Sejvar, J.J.; Marfin, A.A. Manifestations of West Nile neuroinvasive disease. Rev. Med. Virol. 2006, 16, 209-224.
11. Sejvar, J.J.; Bode, A.V.; Marfin, A.A.; Campbell, G.L.; Pape, J.; Biggerstaff, B.J.; Petersen, L.R. West Nile Virus-associated flaccid paralysis outcome. Emerging Infect. Dis. 2006, 12, 514-516.
12. Sejvar, J.J. The long-term outcomes of human West Nile virus infection. Clin. Infect. Dis. 2007, 44, 1617-1624.
13. Sejvar, J.J.; Davis, L.E.; Szabados, E.; Jackson, A.C. Delayed-onset and recurrent limb weakness associated with West Nile virus infection. J. Neurovirol. 2010, 16, 93-100.
14. Nash, D.; Mostashari, F.; Fine, A.; Miller, J.; O'Leary, D.; Murray, K.; Huang, A.; Rosenberg, A.; Greenberg, A.; Sherman, M.; et al. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 2001, 344, 1807-1814.
15. Chowers, M.Y.; Lang, R.; Nassar, F.; Ben-David, D.; Giladi, M.; Rubinshtein, E.; Itzhaki, A.; Mishal, J.; Siegman-Igra, Y.; Kitzes, R.; et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerging Infect. Dis. 2001, 7, 675-678.
16. Huhn, G.D.; Austin, C.; Langkop, C.; Kelly, K.; Lucht, R.; Lampman, R.; Novak, R.; Haramis, L.; Boker, R.; Smith, S.; et al. The emergence of west nile virus during a large outbreak in Illinois in 2002. Am. J. Trop. Med. Hyg. 2005, 72, 768-776.
17. Glass, W.G.; McDermott, D.H.; Lim, J.K.; Lekhong, S.; Yu, S.F.; Frank, W.A.; Pape, J.; Cheshier, R.C.; Murphy, P.M. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 2006, 203, 35-40.
18. Mashimo, T.; Lucas, M.; Simon-Chazottes, D.; Frenkiel, M.-P.; Montagutelli, X.; Ceccaldi, P.-E.; Deubel, V.; Guenet, J.-L.; Despres, P. A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. USA 2002, 99, 11311-11316.
19. Lim, J.K.; Lisco, A.; McDermott, D.H.; Huynh, L.; Ward, J.M.; Johnson, B.; Johnson, H.; Pape, J.; Foster, G.A.; Krysztof, D.; et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009, 5, e1000321.
20. Bigham, A.W.; Buckingham, K.J.; Husain, S.; Emond, M.J.; Bofferding, K.M.; Gildersleeve, H.; Rutherford, A.; Astakhova, N.M.; Perelygin, A.A.; Busch, M.P.; et al. Host genetic risk factors for West Nile Virus infection and disease progression. PLoS ONE 2011, 6, e24745.
21. Chambers, T.J.; Hahn, C.S.; Galler, R.; Rice, C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990, 44, 649-688.
22. Brinton, M.A. The molecular biology of West Nile Virus: A new invader of the western hemisphere. Annu. Rev. Microbiol. 2002, 56, 371-402.
23. Mackenzie, J.M.; Westaway, E.G. Assembly and maturation of the flavivirus kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol. 2001, 75, 10787-10799.
24. Elshuber, S.; Allison, S.L.; Heinz, F.X.; Mandl, C.W. Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J. Gen. Virol. 2003, 84, 183-191.
25. Guirakhoo, F.; Bolin, R.A.; Roehrig, J.T. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology 1992, 191, 921-931.
26. Stadler, K.; Allison, S.L.; Schalich, J.; Heinz, F.X. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 1997, 71, 8475-8481.
27. Mukhopadhyay, S.; Kim, B.-S.; Chipman, P.R.; Rossmann, M.G.; Kuhn, R.J. Structure of West Nile virus. Science 2003, 302, 248.
28. Byrne, S.N.; Halliday, G.M.; Johnston, L.J.; King, N.J. Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J. Invest. Dermatol. 2001, 117, 702-709.
29. Lim, P.-Y.; Behr, M.J.; Chadwick, C.M.; Shi, P.-Y.; Bernard, K.A. Keratinocytes are cell targets of West Nile Virus in vivo. J. Virol. 2011, 85, 5197-5201.
30. Bourne, N.; Scholle, F.; Silva, M.C.; Rossi, S.L.; Dewsbury, N.; Judy, B.; De Aguiar, J.B.; Leon, M.A.; Estes, D.M.; Fayzulin, R.; Mason, P.W. Early production of type I interferon during West Nile virus infection: Role for lymphoid tissues in IRF3-independent interferon production. J. Virol. 2007, 81, 9100-9108.
31. Purtha, W.E.; Chachu, K.A.; Virgin, H.W., 4th; Diamond, M.S. Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling. J. Virol. 2008, 82, 10964-10974.
32. Wang, T.; Scully, E.; Yin, Z.; Kim, J.H.; Wang, S.; Yan, J.; Mamula, M.; Anderson, J.F.; Craft, J.; Fikrig, E. IFN-γ-Producing γδ T cells help control murine West Nile Virus infection. J. Immunol. 2003, 171, 2524-2531.
33. Vargin, V.V.; Semenov, B.F. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta. Virol. 1986, 30, 303-308.
34. Bai, F.; Kong, K.-F.; Dai, J.; Qian, F.; Zhang, L.; Brown, C.R.; Fikrig, E.; Montgomery, R.R. A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J. Infect. Dis. 2010, 202, 1804-1812.
35. Diamond, M.S.; Shrestha, B.; Marri, A.; Mahan, D.; Engle, M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 2003, 77, 2578-2586.
36. Eldadah, A.H.; Nathanson, N. Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain. Am. J. Epidemiol. 1967, 86, 776-790.
37. Diamond, M.S.; Sitati, E.M.; Friend, L.D.; Higgs, S.; Shrestha, B.; Engle, M. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 2003, 198, 1853-1862.
38. Samuel, M.A.; Diamond, M.S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79, 13350-13361.
39. Shrestha, B.; Samuel, M.A.; Diamond, M.S. CD8+ T cells require perforin to clear West Nile Virus from infected neurons. J. Virol. 2006, 80, 119-129.
40. Shrestha, B.; Diamond, M.S. Role of CD8+ T cells in control of west Nile Virus infection. J. Virol. 2004, 78, 8312-8321.
41. Shrestha, B.; Pinto, A.K.; Green, S.; Bosch, I.; Diamond, M.S. CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons. J. Virol. 2012, 86, 8937-8948.
42. Daffis, S.; Samuel, M.A.; Keller, B.C.; Gale, M.; Diamond, M.S. Cell-Specific IRF-3 responses protect against west Nile Virus infection by interferon-dependent and-independent mechanisms. PLoS Pathog. 2007, 3, e106.
43. Chambers, T.J.; Diamond, M.S. Pathogenesis of flavivirus encephalitis. Adv. Virus Res. 2003, 60, 273-342.
44. Wang, T.; Town, T.; Alexopoulou, L.; Anderson, J.F.; Fikrig, E.; Flavell, R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10, 1366-1373.
45. Diamond, M.S.; Klein, R.S. West Nile virus: Crossing the blood-brain barrier. Nat. Med. 2004, 10, 1294-1295.
46. Diniz, J.A.P.; Da Rosa, A.P.A.T.; Guzman, H.; Xu, F.; Xiao, S.-Y.; Popov, V.L.; Vasconcelos, P.F.C.; Tesh, R.B. West Nile virus infection of primary mouse neuronal and neuroglial cells: The role of astrocytes in chronic infection. Am. J. Trop. Med. Hyg. 2006, 75, 691-696.
47. Daffis, S.; Samuel, M.A.; Suthar, M.S.; Gale, M., Jr; Diamond, M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 2008, 82, 10349-10358.
48. Shrestha, B.; Gottlieb, D.; Diamond, M.S. Infection and injury of neurons by West Nile encephalitis virus. J. Virol. 2003, 77, 13203-13213.
49. Samuel, M.A.; Wang, H.; Siddharthan, V.; Morrey, J.D.; Diamond, M.S. Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc. Natl. Acad. Sci. USA 2007, 104, 17140-17145.
50. Morrey, J.D.; Siddharthan, V.; Wang, H.; Hall, J.O.; Skirpstunas, R.T.; Olsen, A.L.; Nordstrom, J.L.; Koenig, S.; Johnson, S.; Diamond, M.S. West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons. J. Neurovirol. 2008, 14, 152-163.
51. Ballabh, P.; Braun, A.; Nedergaard, M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16, 1-13.
52. Johnson, R.T.; Mims, C.A. Pathogenesis of Viral infections of the nervous system. New Engl. J. Med. 1968, 278, 84-92.
53. Johnson, R.T.; Mims, C.A. Pathogenesis of viral infections of the nervous system. New Engl. J. Med. 1968, 278, 23-30.
54. de Vries, H.E.; Blom-Roosemalen, M.C.M.; van Oosten, M.; de Boer, A.G.; van Berkel, T.J. C.; Breimer, D.D.; Kuiper, J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 1996, 64, 37-43.
55. Fiala, M.; Looney, D.J.; Stins, M.; Way, D.D.; Zhang, L.; Gan, X.; Chiappelli, F.; Schweitzer, E.S.; Shapshak, P.; Weinand, M.; et al. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 1997, 3, 553-564.
56. Sultana, H.; Neelakanta, G.; Foellmer, H.G.; Montgomery, R.R.; Anderson, J.F.; Koski, R.A.; Medzhitov, R.M.; Fikrig, E. Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling. J. Immunol. 2012, 189, 3150-3158.
57. Wang, P.; Dai, J.; Bai, F.; Kong, K.-F.; Wong, S.J.; Montgomery, R.R.; Madri, J.A.; Fikrig, E. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J. Virol. 2008, 82, 8978-8985.
58. Verma, S.; Kumar, M.; Gurjav, U.; Lum, S.; Nerurkar, V.R. Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology 2010, 397, 130-138.
59. Hunsperger, E.A.; Roehrig, J.T. Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice. J. Neurovirol. 2006, 12, 129-139.
60. Monath, T.P.; Cropp, C.B.; Harrison, A.K. Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab. Invest. 1983, 48, 399-410.
61. Dietzschold, B.; Schnell, M.; Koprowski, H. Pathogenesis of rabies. Curr. Top. Microbiol. Immunol. 2005, 292, 45-56.
62. Kramer-Hämmerle, S.; Rothenaigner, I.; Wolff, H.; Bell, J.E.; Brack-Werner, R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 2005, 111, 194-213.
63. Wang, S.; Welte, T.; McGargill, M.; Town, T.; Thompson, J.; Anderson, J.F.; Flavell, R.A.; Fikrig, E.; Hedrick, S.M.; Wang, T. Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J. Immunol. 2008, 181, 2084-2091.
64. Garcia-Tapia, D.; Loiacono, C.M.; Kleiboeker, S.B. Replication of West Nile virus in equine peripheral blood mononuclear cells. Vet. Immunol. Immunopathol. 2006, 110, 229-244.
65. Brown, A.N.; Kent, K.A.; Bennett, C.J.; Bernard, K.A. Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates. Virology 2007, 368, 422.
66. Verma, S.; Lo, Y.; Chapagain, M.; Lum, S.; Kumar, M.; Gurjav, U.; Luo, H.; Nakatsuka, A.; Nerurkar, V.R. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. Virology 2009, 385, 425-433.
67. Beasley, D.W.C.; Li, L.; Suderman, M.T.; Barrett, A.D.T. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002, 296, 17-23.
68. Samuel, M.A.; Morrey, J.D.; Diamond, M.S. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile Virus encephalitis. J. Virol. 2007, 81, 2614-2623.
69. Ramanathan, M.P.; Chambers, J.A.; Pankhong, P.; Chattergoon, M.; Attatippaholkun, W.; Dang, K.; Shah, N.; Weiner, D.B. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology 2006, 345, 56-72.
70. del Carmen Parquet, M.; Kumatori, A.; Hasebe, F.; Morita, K.; Igarashi, A. West Nile virus-induced bax-dependent apoptosis. FEBS Letters 2001, 500, 17-24.
71. Medigeshi, G.R.; Lancaster, A.M.; Hirsch, A.J.; Briese, T.; Lipkin, W.I.; DeFilippis, V.; Früh, K.; Mason, P.W.; Nikolich-Zugich, J.; Nelson, J.A. West Nile Virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J. Virol. 2007, 81, 10849-10860.
72. Hail, N.; Carter, B.; Konopleva, M.; Andreeff, M. Apoptosis effector mechanisms: A requiem performed in different keys. Apoptosis 2006, 11, 889-904.
73. Kroemer, G.; Martin, S.J. Caspase-independent cell death. Nat. Med. 2005, 11, 725-730.
74. Chu, J.J.H.; Ng, M.L. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J. Gen. Virol. 2003, 84, 3305-3314.
75. Kumar, M.; Verma, S.; Nerurkar, V.R. Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. J. Neuroinflammation 2010, 7, 73.
76. Zhang, B.; Patel, J.; Croyle, M.; Diamond, M.S.; Klein, R.S. TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis. J. Neuroimmunol. 2010, 224, 28-38.
77. Bradl, M.; Hohlfeld, R. Molecular pathogenesis of neuroinflammation. J. Neurol. Neurosurg. Psychiatry 2003, 74, 1364-1370.
78. Power, C.; Johnson, R.T. Neuroimmune and neurovirological aspects of human immunodeficiency virus infection. Adv. Virus Res. 2001, 56, 389-433.
79. Chen, C.-J.; Ou, Y.-C.; Lin, S.-Y.; Raung, S.-L.; Liao, S.-L.; Lai, C.-Y.; Chen, S.-Y.; Chen, J.-H. Glial activation involvement in neuronal death by Japanese encephalitis virus infection. J. Gen. Virol. 2010, 91, 1028-1037.
80. Schachtele, S.; Hu, S.; Little, M.; Lokensgard, J. Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J. Neuroimmunol. 2010, 7, 35.
81. McGavern, D.B.; Kang, S.S. Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 2011, 11, 318-329.
82. Griffin, D.E. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 2003, 3, 493-502.
83. Lazear, H.M.; Pinto, A.K.; Vogt, M.R.; Gale, M., Jr; Diamond, M.S. Beta interferon controls West Nile virus infection and pathogenesis in mice. J. Virol. 2011, 85, 7186-7194.
84. Szretter, K.J.; Daffis, S.; Patel, J.; Suthar, M.S.; Klein, R.S.; Gale, M., Jr; Diamond, M.S. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J. Virol. 2010, 84, 12125-12138.
85. Town, T.; Bai, F.; Wang, T.; Kaplan, A.T.; Qian, F.; Montgomery, R.R.; Anderson, J.F.; Flavell, R.A.; Fikrig, E. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 2009, 30, 242-253.
86. Daffis, S.; Samuel, M.A.; Suthar, M.S.; Keller, B.C.; Gale, M., Jr; Diamond, M.S. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J. Virol. 2008, 82, 8465-8475.
87. Szretter, K.J.; Brien, J.D.; Thackray, L.B.; Virgin, H.W.; Cresswell, P.; Diamond, M.S. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J. Virol. 2011, 85, 11557-11566.
88. Samuel, M.A.; Whitby, K.; Keller, B.C.; Marri, A.; Barchet, W.; Williams, B.R.G.; Silverman, R.H.; Gale, M., Jr; Diamond, M.S. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 2006, 80, 7009-7019.
89. Klein, R.S.; Lin, E.; Zhang, B.; Luster, A.D.; Tollett, J.; Samuel, M.A.; Engle, M.; Diamond, M.S. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 2005, 79, 11457-11466.
90. Zhang, B.; Chan, Y.K.; Lu, B.; Diamond, M.S.; Klein, R.S. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 2008, 180, 2641-2649.
91. Glass, W.G.; Lim, J.K.; Cholera, R.; Pletnev, A.G.; Gao, J.-L.; Murphy, P.M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005, 202, 1087-1098.
92. Shirato, K.; Kimura, T.; Mizutani, T.; Kariwa, H.; Takashima, I. Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J. Med. Virol. 2004, 74, 507-513.
93. Getts, D.R.; Terry, R.L.; Getts, M.T.; Müller, M.; Rana, S.; Shrestha, B.; Radford, J.; Rooijen, N.V.; Campbell, I.L.; King, N.J. C. Ly6c+ "nflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 2008, 205, 2319-2337.
94. Lim, J.K.; Obara, C.J.; Rivollier, A.; Pletnev, A.G.; Kelsall, B.L.; Murphy, P.M. Chemokine Receptor Ccr2 is critical for monocyte accumulation and survival in west nile virus encephalitis. J. Immunol. 2011, 186, 471-478.
95. Wang, P.; Bai, F.; Zenewicz, L.A.; Dai, J.; Gate, D.; Cheng, G.; Yang, L.; Qian, F.; Yuan, X.; Montgomery, R.R.; Flavell, R.A.; Town, T.; Fikrig, E. IL-22 Signaling contributes to west nile encephalitis pathogenesis. PLoS ONE 2012, 7, e44153.
96. Sitati, E.M.; Diamond, M.S. CD4+ T-Cell responses are required for clearance of west Nile virus from the central nervous system. J. Virol. 2006, 80, 12060-12069.
97. Sitati, E.; McCandless, E.E.; Klein, R.S.; Diamond, M.S. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile Virus encephalitis. J. Virol. 2007, 81, 9801-9811.
98. Shrestha, B.; Zhang, B.; Purtha, W.E.; Klein, R.S.; Diamond, M.S. Tumor necrosis factor alpha protects against lethal West Nile Virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J. Virol. 2008, 82, 8956-8964.
99. Chevalier, G.; Suberbielle, E.; Monnet, C.; Duplan, V.; Martin-Blondel, G.; Farrugia, F.; Le Masson, G.; Liblau, R.; Gonzalez-Dunia, D. Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog. 2011, 7, e1002393.
100. Harty, J.T.; Badovinac, V.P. Influence of effector molecules on the CD8+ T cell response to infection. Curr. Opin. Immunol. 2002, 14, 360-365.
101. Russell, J.H.; Ley, T.J. Lymphocyte-Mediated Cytotoxicity. Annu. Rev. Immunol. 2002, 20, 323-370.
102. Shresta, S.; Pham, C.T.; Thomas, D.A.; Graubert, T.A.; Ley, T.J. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 1998, 10, 581-587.
103. Shrestha, B.; Diamond, M.S. Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile Virus infection in the central nervous system. J. Virol. 2007, 81, 11749-11757.
104. Krzyżowska, M.; Cymerys, J.; Winnicka, A.; Niemiałtowski, M. Involvement of fas and fasL in ectromelia virus-induced apoptosis in mouse brain. Virus Res. 2006, 115, 141-149.
105. Nagata, S. Apoptosis by death factor. Cell 1997, 88, 355-365.
106. Pruitt, A.A. Central nervous system infections in cancer patients. Semin. Neurol. 2004, 24, 435-452.
107. Wang, Y.; Lobigs, M.; Lee, E.; Müllbacher, A. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 2003, 77, 13323-13334.
108. Szretter, K.J.; Daniels, B.P.; Cho, H.; Gainey, M.D.; Yokoyama, W.M.; Gale, M., Jr; Virgin, H.W.; Klein, R.S.; Sen, G.C.; Diamond, M.S. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and-independent mechanisms of host restriction in vivo. PLoS Pathog. 2012, 8, e1002698.
109. Stewart, B.S.; Demarest, V.L.; Wong, S.J.; Green, S.; Bernard, K.A. Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection. BMC Immunol. 2011, 12, 6.
110. Appler, K.K.; Brown, A.N.; Stewart, B.S.; Behr, M.J.; Demarest, V.L.; Wong, S.J.; Bernard, K.A. Persistence of West Nile Virus in the central nervous system and periphery of mice. PLoS ONE 2010, 5, e10649.
111. Slavin, H.B. Persistence of the virus of St. Louis encephalitis in the central nervous system of mice for over five months. J. Bacteriol. 1943, 46, 113-116.
112. Pogodina, V.V.; Bochkova, N.G.; Levina, L.S. Persistence of tick-borne encephalitis virus in monkeys. VII. Some features of the immune response. Acta. Virol. 1984, 28, 407-415.
113. Pogodina, V.V.; Frolova, M.P.; Malenko, G.V.; Fokina, G.I.; Levina, L.S.; Mamonenko, L.L.; Koreshkova, G.V.; Ralf, N.M. Persistence of tick-borne encephalitis virus in monkeys. I. Features of experimental infection. Acta. Virol. 1981, 25, 337-343.
114. Zlotnik, I.; Carter, G.B.; Grant, D.P. The persistence of louping ill virus in immunosuppressed guinea-pigs. Br. J. Exp. Pathol. 1971, 52, 395-407.
115. Pogodina, V.V.; Frolova, M.P.; Malenko, G.V.; Fokina, G.I.; Koreshkova, G.V.; Kiseleva, L.L.; Bochkova, N.G.; Ralph, N.M. Study on West Nile virus persistence in monkeys. Arch. Virol. 1983, 75, 71-86.
116. Xiao, S.Y.; Guzman, H.; Zhang, H.; Travassos da Rosa, A.P.; Tesh, R.B. West Nile virus infection in the golden hamster (Mesocricetus auratus): A model for West Nile encephalitis. Emerging Infect. Dis. 2001, 7, 714-721.
117. Siddharthan, V.; Wang, H.; Motter, N.E.; Hall, J.O.; Skinner, R.D.; Skirpstunas, R.T.; Morrey, J.D. Persistent West Nile Virus associated with a neurological sequela in hamsters identified by motor unit number estimation. J. Virol. 2009, 83, 4251-4261.
118. Nolan, M.S.; Podoll, A.S.; Hause, A.M.; Akers, K.M.; Finkel, K.W.; Murray, K.O. Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the houston West Nile Virus cohort. PLoS ONE 2012, 7, e40374.
119. Murray, K.; Walker, C.; Herrington, E.; Lewis, J.A.; McCormick, J.; Beasley, D.W.C.; Tesh, R.B.; Fisher-Hoch, S. Persistent infection with West Nile virus years after initial infection. J. Infect. Dis. 2010, 201, 2-4.
120. McCandless, E.E.; Zhang, B.; Diamond, M.S.; Klein, R.S. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. PNAS 2008, 105, 11270-11275.
121. Getts, D.R.; Terry, R.L.; Getts, M.T.; Müller, M.; Rana, S.; Deffrasnes, C.; Ashhurst, T.M.; Radford, J.; Hofer, M.; Thomas, S.; et al. Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. J. Neuroimmunol. 2012, 9, 246.
122. Diamond, M.S. Progress on the development of therapeutics against West Nile virus. Antivir. Res. 2009, 83, 214-227.
123. Dai, J.; Wang, P.; Bai, F.; Town, T.; Fikrig, E. ICAM-1 Participates in the entry of West Nile virus into the central nervous system. J. Virol. 2008, 82, 4164-4168.
124. Shen, J.; T-To, S.S.; Schrieber, L.; King, N.J. Early e-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 1997, 71, 9323-9332.
125. Warke, R.V.; Martin, K.J.; Giaya, K.; Shaw, S.K.; Rothman, A.L.; Bosch, I. TRAIL Is a novel antiviral protein against Dengue virus. J. Virol. 2008, 82, 555-564.